Globus Medical (GMED) Cash from Operations Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Globus Medical | 10.79 Bn | 10.16 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.06% |
| Dec 31, 2025 | 25.39% |
| Sep 30, 2025 | 36.21% |
| Jun 30, 2025 | 27.55% |
| Mar 31, 2025 | 33.20% |
| Dec 31, 2024 | 31.10% |
| Sep 30, 2024 | 29.52% |
| Jun 30, 2024 | 19.15% |
| Mar 31, 2024 | 5.97% |
| Sep 30, 2023 | -12.08% |
| Jun 30, 2023 | 1.04% |
| Mar 31, 2023 | 0.39% |
| Dec 31, 2022 | 7.37% |
| Sep 30, 2022 | -1.10% |
| Jun 30, 2022 | 7.26% |
| Mar 31, 2022 | -3.52% |
| Dec 31, 2021 | 23.69% |
| Sep 30, 2021 | 12.62% |
| Jun 30, 2021 | 20.53% |
| Mar 31, 2021 | 2.73% |
| Dec 31, 2020 | 11.69% |
| Sep 30, 2020 | 12.13% |
| Jun 30, 2020 | 11.88% |
| Mar 31, 2020 | 4.05% |
| Dec 31, 2019 | 94.62% |
| Sep 30, 2019 | 9.40% |
| Jun 30, 2019 | 12.84% |
| Mar 31, 2019 | 6.05% |
| Sep 30, 2018 | 23.42% |
| Jun 30, 2018 | 29.94% |
| Mar 31, 2018 | 23.40% |
| Dec 31, 2017 | 12.63% |
| Sep 30, 2017 | 15.54% |
| Jun 30, 2017 | 16.65% |
| Mar 31, 2017 | 18.52% |
| Dec 31, 2016 | 3.06% |
| Sep 30, 2016 | 12.83% |